Free Shipping On Orders $75+
Skip to main content
Canalevia-CA1 crofelemer delayed-release prescription tablets for dogs

Canalevia-CA1 Delayed-Release Tablets

Veterinarian Prescription (Rx) Required
Free Shipping on orders over $75 
Low Price Match Guarantee

  • Prescription antidiarrheal medication conditionally approved by the FDA for dogs
  • Indicated for the treatment of chemotherapy-induced diarrhea in dogs
  • Contains crofelemer, a botanical drug substance derived from the red latex of Croton lechleri
  • Convenient oral delayed-release tablet administered twice daily for 3 days according to the dog's body weight

Price: $9.58
Price: $9.58
$8.62 -10% future orders
$8.62 -10% future orders
$8.62 -10% future orders
$8.62 -10% future orders
$8.62 -10% future orders
$8.62 -10% future orders
$8.62 -10% future orders
$8.62 -10% future orders
Save $25.03 a year with Autoship
Save $11.68 a year with Autoship
Save $8.34 a year with Autoship
Save $5.84 a year with Autoship
Save $3.89 a year with Autoship
Save $2.92 a year with Autoship
Save $1.95 a year with Autoship
Save $0.96 a year with Autoship
Licensed U.S. PharmacyReal pharmacists.
SKU : 11060_-RX
How to Order Prescriptions

Description

Canalevia-CA1 (crofelemer delayed-release tablets) is a prescription antidiarrheal medication conditionally approved by the FDA for the treatment of chemotherapy-induced diarrhea in dogs. It is an enteric-coated oral tablet containing crofelemer, a botanical drug substance derived from the red latex of Croton lechleri.

Canalevia-CA1 is available only by prescription and should be used under veterinary supervision. Before treatment, infectious causes of diarrhea should be ruled out to help ensure appropriate management of the dog's condition.

Uses & Benefits

  • Indicated for chemotherapy-induced diarrhea in dogs
  • Prescription medication specifically formulated for canine use
  • Provides an oral treatment option
  • Short, 3-day labeled administration period
  • May be administered with or without food
  • Delayed-release, enteric-coated tablet formulation
  • Conditionally approved by the FDA pending a full demonstration of effectiveness

How It Works

Canalevia-CA1 contains crofelemer. Crofelemer acts locally within the gastrointestinal tract to inhibit certain chloride ion channels involved in intestinal fluid secretion. This activity helps normalize the movement of water into the intestinal lumen.

The delayed-release tablet is enteric coated and should be swallowed intact so that the formulation functions as intended.

Indications

Canalevia-CA1 is conditionally approved by the FDA for the treatment of chemotherapy-induced diarrhea in dogs.

Conditional approval means the FDA has determined that the drug has met the applicable requirements for safety and manufacturing and has a reasonable expectation of effectiveness while the sponsor continues to collect the effectiveness data required for full approval. Canalevia-CA1 is conditionally approved pending a full demonstration of effectiveness under application number 141-552.

Ingredients

Active Ingredients:

Crofelemer — 125 mg per delayed-release tablet.

Inactive Ingredients:

Refer to the current manufacturer label for complete inactive ingredient information.

Directions

For oral administration in dogs only.

Give Canalevia-CA1 twice daily for 3 days according to the dog's body weight. Tablets may be administered with or without food.

Tablets must not be broken, crushed, or chewed. If a tablet is chewed, the FDA-approved labeling states that one additional dose may be administered.

Weight / Dosage

Dog Weight Dosage Frequency Duration
140 lbs or less 1 tablet Twice daily 3 days
Over 140 lbs 2 tablets Twice daily 3 days

Each tablet contains 125 mg of crofelemer.

Administer exactly as prescribed by your veterinarian. Follow all dosing and administration instructions provided on the prescription label and by your veterinarian. Do not adjust the dose, frequency, route, or duration of administration unless directed by your veterinarian.

Cautions

  • Federal law restricts this drug to use by or on the order of a licensed veterinarian.
  • For oral use in dogs only.
  • Use only as directed.
  • Do not use in dogs with a known hypersensitivity to crofelemer.
  • Do not break, crush, or chew the tablets.
  • Not for use in humans.
  • Keep medication in a secure location out of reach of children and other animals.
  • Contact a physician in case of accidental ingestion by a person.
  • Infectious causes of diarrhea should be ruled out before treatment.

Possible Side Effects

The most commonly reported adverse reactions during the field study included:

  • Decreased appetite / Decreased activity / Dehydration / Abdominal pain / Vomiting

Other adverse events may occur. Contact your veterinarian if your dog develops a concerning or persistent reaction while receiving Canalevia-CA1.

Precautions

Before administering Canalevia-CA1, infectious causes of diarrhea should be ruled out. Using Canalevia-CA1 in a dog whose diarrhea is caused by an infectious condition may delay appropriate treatment.

The safe use of Canalevia-CA1 has not been evaluated in dogs that are pregnant, lactating, or intended for breeding.

Canalevia-CA1 should only be used for its labeled indication and according to veterinarian directions. Federal law prohibits using this conditionally approved drug other than as directed in its labeling.

Storage

Store at 68°F to 77°F (20°C to 25°C). Excursions are permitted between 59°F and 86°F (15°C to 30°C). Keep the medication securely stored and out of reach of children and animals.

Disposal

Dispose of expired or unused medication according to veterinarian, pharmacy, or applicable local requirements. Do not flush medication unless specifically instructed to do so.

Loading...